Human immunodeficiency virus infection, inducible nitric oxide synthase expression, and microglial activation: Pathogenetic relationship to the acquired immunodeficiency syndrome dementia complex

Annals of Neurology

Volumn 46, Issue 2, 1999, Pages 207-216

  Rostasy, Kevin ^a   Monti, Laura ^a   Yiannoutsos, Constantin ^b   Kneissl, Michelle ^a   Bell, Jeanne ^c   Kemper, Thomas L ^d   Hedreen, John C ^a   Navia, Bradford A ^a,e,f  

^a TUFTS MEDICAL CENTER   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c Harvard School of Public Health ^*  (United Kingdom)

^d BOSTON MEDICAL CENTER   (United States)

^e Tufts Neurology Program   (United States)

^f TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 41; HLA DR ANTIGEN; NITRIC OXIDE SYNTHASE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BASAL GANGLION; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DISEASE SEVERITY; FEMALE; FRONTAL LOBE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MACROPHAGE; MALE; MICROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; WHITE MATTER;

ADULT; AIDS DEMENTIA COMPLEX; BRAIN; FEMALE; HIV INFECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; MIDDLE AGED; NITRIC OXIDE SYNTHASE; PROSPECTIVE STUDIES;

EID: 0032839688     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(199908)46:2<207::AID-ANA10>3.0.CO;2-4     Document Type: Article

References (64)

1. Navia BA, Jordan B, Price RW. The AIDS dementia complex: I. Clinical features. Ann Neurol 1986;19:517-524
2. Navia BA, Cho E, Petito C, Price RW. The AIDS dementia complex: II. Ann Neurol 1986;19:525-535
3. Price RW, Brew B, Sidtis J, et al. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 1988;239:586-592
4. Bacellar H, Munoz A, Miller E. Temporal trends in the incidence of HIV-1-related neurological diseases: multicenter AIDS cohort study. Neurology 1994;44:1892-1900
5. Lipton SA, Gendelman H. Dementia associated with the acquired immunodeficiency syndrome. N Engl J Med 1995;332: 934-940
6. Wiley C, Achim C. Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann Neurol 1994;36:673-676
7. Glass JD, Wesselingh SL, Seines OA, McArthur JC. Clinical-neuropathologic correlation in HIV-associated dementia. Neurology 1993;43:2230-2237
8. Petito CK, Cash KS. Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in postmortem brain. Ann Neurol 1992;32:658-666
9. Power C, Kong PA, Crawford TO, et al. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann Neurol 1993;34:339-350
10. Ketzler S, Weis S, Haug H, Budka H. Loss of neurons in the frontal cortex in AIDS brains. Acta Neuropathol 1990;80: 92-94
11. Wiley C, Masliah E, Morey M, et al. Neocortical damage during HIV infection. Ann Neurol 1991;29:651-657
12. Everall I, Luthert P, Lantos P. Neuronal loss in the frontal cortex in HIV infection. Lancet 1991;337:1119-1121
13. Masliah E, Achim C, Ge N, et al. Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol 1992;32:321-329
14. Seilhean D, Duyckaerts C, Vazeux R, et al. HIV-1 associated cognitive/motor complex: absence of neuronal loss in the cerebral cortex. Neurology 1993;43:1492-1499
15. Everall IP, Luthert PJ, Lantos PL. A review of neuronal damage in human immunodeficiency virus infection: its assessment, possible mechanism and relationship to dementia. J Neuropathol Exp Neurol 1993;52:561-566
16. Everall IP, Luthert PJ, Lantos PL. Neuronal number and volume alterations in the neocortex of HIV infected individuals. J Neurol Neurosurg Psychiatry 1993;56:481-486
17. Masliah E, Heaton RK, Marcotte TD, et al. Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. Ann Neurol 1997;42:963-972
18. Wiley CA, Schrier RD, Nelson JA, et al. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sei USA 1986;83:7089-7093
19. Koenig S, Gendelman HE, Orenstein JM, et al. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986;233:1089-1093
20. Gabuzda D, Ho D, de la Monte S, et al. Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS. Ann Neurol 1986;20:289-295
21. Pumarola-Sune T, Navia B, Cordon-Cardi C. HIV antigen in the brains of patients with the AIDS dementia complex. Ann Neurol 1987;21:490-496
22. Brew B, Rosenblum M, Cronin K, Price R. AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations. Ann Neurol 1995;38:563-570
23. Glass JD, Fedor H, Wesselingh S, McArthur J. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 1995;38:755-762
24. Johnson RT, Glass JD, McArthur JC, et al. Quantitation of human immunodeficiency virus in brains of demented and nondemented patients with acquired immunodeficiency syndrome. Ann Neurol 1996;39:392-395
25. Brennerman DE, Westbrook GL, Fitzgerald SP, et al. Neuronal cell killing by the envelope glycoprotein of HIV and its prevention by vasoactive intestinal peptide. Nature 1988;355:639-642
26. Dreyer EB, Kaiser PK, Offerman IT, et al. HIV-1 coat protein neurotoxicity prevented by calcium antagonists. Science 1990; 250:364-367
27. Giulian D, Vaca K, Noonan CA. Secretion of neurotoxins of mononuclear phagocytes infected with HIV-1. Science 1990; 250:1593-1596
28. Pulliam L, Herndier BG, Tang NM, et al. Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains. J Clin Invest 1991;87:503-512
29. Gelbard HA, Nottet H, Swindells S, et al. Platelet activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. J Virol 1994;68:4628-4635
30. Bukrinsky MI, Nottet H, Schmidtmayerova H, et al. Regulation of nitric oxide synthase in human immunodeficiency virus type 1-infected monocytes: implications for HIV-associated neurological disease. J Exp Med 1995;181:735-745
31. Magnuson DSK, Knudsen BE, Geiger JD, et al. Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann Neurol 1995;37:373-380
32. Adamson DC, Wildemann B, Sasaki M, et al. Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp 41. Science 1996;274:1917-1920
33. Tyor WR, Glass JD, Griffin JW, et al. Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol 1992;31:349-360
34. Wesselingh SL, Power C, Glass JD, et al. Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann Neurol 1993;33:576-582
35. American Academy of Neurology AIDS task force. Report of a working group of the American Academy of Neurology AIDS task force: nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology 1991;41:778-785
36. Price RW, Brew BJ. The AIDC dementia complex. J Infect Dis 1988;158:1079-1083
37. Hedreen JC, Mucci LA. Antigen retrieval for paraffin section immunocytochemistry with antibodies commonly used in studies of degenerative diseases. Soc Neurosci Abstr 1995;21:1802 (Abstract)
38. Lee SC, Dickson DW, Liu W, Brosnan CF. Activation of nitric synthase pathways in human fetal astrocytes by IL-1β and IFNγ. J Neuroimmunol 1993;46:19-24
39. Wiley CA, Achim CL, Schrier RD, et al. Relationship of cerebrospinal immune activation associated factors to HIV encephalitis. AIDS 1992;6:1299-1307
40. Weis S, Neuhaus B, Mehraein P. Activation of microglia in HIV infected brains is not dependent on the presence of HIV-1 antigens. Neuroreport 1994;5:1514-1516
41. Rottenberg D, Moeller J, Strother S, et al. The metabolic pathology of the AIDS dementia complex. Ann Neurol 1987;22: 700-706
42. Tracey I, Hamberg LM, Guimares AR, et al. Increased cerebral blood volume in HIV seropositive subjects detected by functional MRI. Neurology 1998;50:1821-1826
43. Meng W, Tobin JR, Busija DW. Glutamate-induced vasodilatation is mediated by nitric oxide through N-methyl-D-aspartate receptors. Stroke 1995;26:857-863
44. Dawson VL, Dawson TM, London ED, et al. Nitric oxide mediates glutamate neurotoxicity in primary cultures. Proc Natl Acad Sci USA 1991;88:6368-6371
45. Dawson VL, Dawson TM, Uhl GR, Synder SH. HIV-1 coat protein neurotoxicity mediated by nitric oxide in primary cultures. Proc Natl Acad USA 1993;90:3256-3259
46. Mollace V, Colasanti M, Persichini T, et al. HIV gp-120 glycoprotein stimulates the inducible isoform of NO synthase in human cultured astrocytoma cells. Biochem Biophys Res Commun 1993;194:439-445
47. Ghorpade A, Che M, Gendelman HE. Defining the cellular regulation of nitric oxide in HIV encephalitis. Fifth Conference on Retroviruses and Opportunistic Infections, Chicago, 1998: 443
48. Nottet Hans SLM, Jett M, Flanagan CR, et al. A regulatory role for astrocytes in HIV-1 encephalitis. J Immunol 1995;154: 3567-3581
49. Nath A, Psooy K, Martin C, et al. Identification of human immunodeficiency virus type 1 tat epitope that is neuroexcitatory and neurotonic. J Virol 1996;70:1475-1480
50. Philippon V, Vellutini C, Gambararelli G, et al. The basic domain of the lentiviral tat protein is responsible for damages in mouse brain: involvement of cytokines. Virology 1994;205: 519-529
51. Westendorp MO, Shatrov VA, Schulze-Osthoff K, et al. HIV Tat potentiates TNF-induced NFκB activation and cytotoxicity by altering the redox state. EMBO J 1995;14:546-554
52. Talley A, Dewhurst S, Perry S, et al. Tumor necrosis factor alpha induced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and die genes bcl-2 and crm-A. Mol Cell Biol 1995;15:2359-2366
53. Shi B, Raina J, Lorenzo A, et al. Neuronal apoptosis induced by HIV-1 Tat protein and TNF-α: potentiation of neurotoxicity by oxidative stress and implications for HIV-1 dementia. J Neurovirol 1998;4:281-290
54. New DR, Maggirwar SB, Epstein LG, et al. HIV-1 tat induces neuronal death via tumor necrosis factor alpha and activation of non-N-methyl-D-aspartate receptors by NFkappaB-independent mechanism. J Biol Chem 1998;273:17852-17858
55. Yeung C, Pulliam L, Lau AS. The HIV envelope protein gp120 is toxic to human brain cell cultures through the induction of interleukin-6 and tumor necrosis factor-α. AIDS 1995;9:137-143
56. Merrill JE, Koyanagi Y, Zack J, et al. Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1. J Virol 1992;66:2217-2225
57. Rostasy K, Monti L, Hedreen J, et al. TNFa expression, NFκB activation, and apoptosis in the AIDS dementia complex. Neurology 1999;52:A186 (Abstract)
58. Schmitt FA, Bigley JW, McKinnis R, et al. Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex. N Engl J Med 1988;319:1573-1578
59. Portegeis P, de Gans J, Lange JM, et al. Declining incidence of AIDS dementia complex after introduction of zidovudine treatment, BMJ 1989;299:819-821
60. Hamer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 counts of 200 per cubic millimeter or less. N Engl J Med 1997;337:725-733
61. Saktor N, Skolasky R, Esposito D, et al. Combination antiretroviral therapy including protease inhibitors improves psychomotor speed in HIV infection. Neurology 1998;50:A248 (Abstract)
62. Lipton SA. Memantine prevents HIV coat protein induced neuronal injury in vitro. Neurology 1992;421:1403-1405
63. The Dana Research Consortium on the therapy of HIV dementia and related cognitive disorders. A randomized double-blind placebo controlled trial of deprenyl and thioacetic acid in human immunodeficiency virus-associated cognitive impairment. Neurology 1998;50:645-651
64. Navia BA, Dafni U, Simpson D, et al. A phase I/II trial of nimodipine for HIV-related neurologic complications. Neurology 1998;51:221-228